Debriefing Consult for Postpartum PTSD
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary objective of this study is to determine if a maternal fetal medicine (MFM) debriefing consult six to eight weeks postpartum reduces self-reported post-traumatic stress, depression, and anxiety symptoms following a delivery complicated by severe maternal morbidity (SMM). Individuals with a delivery complicated an intensive care unit (ICU) admission and/or blood product transfusion \>4 units will be included in this study. Participants will be randomized to an intervention or control group; all participants will complete patient questionnaires that screen for post-traumatic stress disorder, depression, and anxiety. Those in the control group will receive a virtual MFM debriefing consult at six weeks postpartum and those in the intervention group will have the option for a consult at twelve weeks postpartum, after the completion of the questionnaires.
Who Is on the Research Team?
Sarah Kilpatrick, MD, PhD
Principal Investigator
Cedars-Sinai Medical Center
Are You a Good Fit for This Trial?
This trial is for people who had a complicated childbirth that required ICU care or received more than 4 units of blood. It focuses on those experiencing stress, anxiety, or depression after delivery.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Virtual maternal fetal medicine debriefing consult
Trial Overview
The study tests if having a virtual consultation with a maternal-fetal medicine specialist six to eight weeks after childbirth helps reduce symptoms of PTSD, depression, and anxiety compared to receiving the consult later.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
At six weeks postpartum, subjects will receive a questionnaire on mental health symptoms. Subjects in the intervention group will then be scheduled for a virtual maternal fetal medicine debriefing consult between six and eight weeks postpartum. At twelve weeks postpartum, subjects will repeat the mental health symptom questionnaire.
At six weeks postpartum, subjects will receive a questionnaire on mental health symptoms. At twelve weeks postpartum, subjects will repeat the mental health symptom questionnaire. Following completion of both questionnaires, subjects in the control group will have the option to complete a virtual maternal fetal medicine debriefing consult.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cedars-Sinai Medical Center
Lead Sponsor
Cedars Sinai Medical Center, Los Angeles, USA
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.